title: Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration.
abstract: Whereas the conventional tissue engineering strategy involves the use of scaffolds combined with appropriate cell types to restore normal functions, the concept of in situ tissue regeneration uses host responses to a target-specific scaffold to mobilize host cells to a site of injury without the need for cell seeding. For this purpose, local delivery of bioactive molecules from scaffolds has been generally used. However, this approach has limited stem cell recruitment into the implants. Thus, we developed a combination of systemic delivery of substance P (SP) and local release of stromal-derived factor-1α (SDF-1α) from an implant. In this study, we examined whether this combined system would significantly enhance recruitment of host stem cells into the implants. Flow cytometry and immunohistochemistry for CD29/CD45, CD146/α-smooth muscle actin, and c-kit demonstrated that this system significantly increased the number of stem cell-like cells within the implants when compared with other systems. In vitro culture of the cells that had infiltrated into the scaffolds from the combined system confirmed that host stem cells were recruited into these implants and indicated that they were capable of differentiation into multiple lineages. These results indicate that this combined system may lead to more efficient tissue regeneration.
authors.affiliation: Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
authors.forename: In Kap
authors.initials: IK
authors.lastname: Ko
authors.forename: Young Min
authors.initials: YM
authors.lastname: Ju
authors.forename: Timothy
authors.initials: T
authors.lastname: Chen
authors.forename: Anthony
authors.initials: A
authors.lastname: Atala
authors.forename: James J
authors.initials: JJ
authors.lastname: Yoo
authors.forename: Sang Jin
authors.initials: SJ
authors.lastname: Lee
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D054377:Chemokine CXCL12 / Q000493:pharmacokinetics*; D002633:Chemotaxis / Q000187:drug effects / Q000502:physiology; D016503:Drug Delivery Systems / Q000379:methods; D005434:Flow Cytometry; D005780:Gelatin; D019344:Lactic Acid; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology; D018377:Neurotransmitter Agents / Q000493:pharmacokinetics; D011091:Polyesters; D011108:Polymers; D019009:Proto-Oncogene Proteins c-kit / Q000378:metabolism; D012038:Regeneration / Q000502:physiology*; D013234:Stem Cells / Q000166:cytology* / Q000502:physiology; D013373:Substance P / Q000493:pharmacokinetics*; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
chemical_list: D054377:Chemokine CXCL12; C515256:Cxcl12 protein, mouse; D018377:Neurotransmitter Agents; D011091:Polyesters; D011108:Polymers; D013373:Substance P; D019344:Lactic Acid; C033616:poly(lactide); D005780:Gelatin; D019009:Proto-Oncogene Proteins c-kit